Table 17.
Cancers | Targeted gene products† | References |
---|---|---|
Cancers with down-regulation of miR-1307-3p | ||
Acting as oncogenes or tumor promoters | ||
CRC | TYMS | Chen et al. (2017a) |
Acting as tumor suppressors | ||
CRC | ISM1 | Zheng et al. (2019a); Yue et al. (2020) |
Cancers with up-regulation of miR-1307-3p | ||
Acting as tumor suppressors | ||
CRC | TRARG1 | Zheng et al. (2019a) |
GC | DAB2IP | Ma et al. (2021b) |
BLCA | SMG1 | Wang et al. (2021b) |
BRCA | SMYD4 | Han et al. (2019) |
HCC | DAB2IP, ISM1 | Chen et al. (2019a); Wang et al. (2019b) |
OVCA | DAPK3 | Zhou et al. (2015) |
PCa | FOXO3 | Qiu and Dou (2017) |
†mRNAs encoding the following proteins: DAB2IP is a tumor suppressor gene encoding DAB2 Interacting Protein, a Ras GTPase-activating protein; DAPK3 is a tumor suppressor gene that codes for serine/threonine Death Associated Protein Kinase 3; FOXO3 is a tumor suppressor gene encoding a transcription factor that activates genes encoding i.a. pro-apoptotic BIM and PUMA; ISM1 codes for Isthmin 1 that acts as an angiogenesis inhibitor; SMG1 is a tumor suppressor gene encoding a protein that can enhance p53 activity (Gewandter et al. 2011); SMYD4 is a tumor suppressor gene involved in the development of breast cancer; TRARG1 codes for Trafficking Regulator of GLUT4